We showed that the selective activation of P2RY1 via its agonist, MRS2365, can induce ERK1/2 phosphorylation and subsequent ELK1/c-Fos/c-Jun phosphorylation, suggesting the crucial role of ERK1/2 signaling in gastric cancer cells (Figure 5). The gene discussed is MAPK3; the disease is gastric cancer.